A detailed history of Wellington Management Group LLP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 20,071 shares of VERA stock, worth $928,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,071
Previous 112,639 82.18%
Holding current value
$928,484
Previous $4.08 Million 78.26%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$34.09 - $46.71 $3.16 Million - $4.32 Million
-92,568 Reduced 82.18%
20,071 $886,000
Q2 2024

Aug 13, 2024

SELL
$33.72 - $48.82 $612,186 - $886,327
-18,155 Reduced 13.88%
112,639 $4.08 Million
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $1.95 Million - $6.43 Million
130,794 New
130,794 $5.64 Million
Q3 2023

Nov 14, 2023

BUY
$13.71 - $19.64 $1.16 Million - $1.66 Million
84,506 New
84,506 $1.16 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.25B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.